Schwager SM - Search Results

1

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.

Shanafelt TD, Rabe KG, Kay NE, Zent CS, Jelinek DF, Reinalda MS, Schwager SM, Bowen DA, Slager SL, Hanson CA, Call TG. Shanafelt TD, et al. Among authors: schwager sm. Cancer. 2010 Oct 15;116(20):4777-87. doi: 10.1002/cncr.25292. Cancer. 2010. PMID: 20578179 Free PMC article.

2

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera.

Tefferi A, Lasho TL, Schwager SM, Strand JS, Elliott M, Mesa R, Li CY, Wadleigh M, Lee SJ, Gilliland DG. Tefferi A, et al. Among authors: schwager sm. Cancer. 2006 Feb 1;106(3):631-5. doi: 10.1002/cncr.21645. Cancer. 2006. PMID: 16369984 Free article.

3

Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.

Dingli D, Schwager SM, Mesa RA, Li CY, Tefferi A. Dingli D, et al. Among authors: schwager sm. Cancer. 2006 Feb 1;106(3):623-30. doi: 10.1002/cncr.21644. Cancer. 2006. PMID: 16369987 Free article.

4

Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.

Dingli D, Schwager SM, Mesa RA, Li CY, Dewald GW, Tefferi A. Dingli D, et al. Among authors: schwager sm. Cancer. 2006 May 1;106(9):1985-9. doi: 10.1002/cncr.21868. Cancer. 2006. PMID: 16568439 Free article.

5

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia.

Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Gangat N, et al. Among authors: schwager sm. Cancer. 2006 Jun 1;106(11):2406-11. doi: 10.1002/cncr.21891. Cancer. 2006. PMID: 16628652 Free article.

6

Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.

Mesa RA, Nagorney DS, Schwager S, Allred J, Tefferi A. Mesa RA, et al. Cancer. 2006 Jul 15;107(2):361-70. doi: 10.1002/cncr.22021. Cancer. 2006. PMID: 16770787 Free article.

7

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia.

Shanafelt TD, Jelinek D, Tschumper R, Schwager S, Nowakowski G, DeWald GW, Kay NE. Shanafelt TD, et al. J Clin Oncol. 2006 Jul 1;24(19):3218-9; author reply 3219-20. doi: 10.1200/JCO.2006.06.1077. J Clin Oncol. 2006. PMID: 16809747 No abstract available.

8

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.

Tefferi A, Huang J, Schwager S, Li CY, Wu W, Pardanani A, Mesa RA. Tefferi A, et al. Cancer. 2007 May 15;109(10):2083-8. doi: 10.1002/cncr.22630. Cancer. 2007. PMID: 17407134 Free article.

9

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

Maddocks-Christianson K, Slager SL, Zent CS, Reinalda M, Call TG, Habermann TM, Bowen DA, Hoyer JD, Schwager S, Jelinek DF, Kay NE, Shanafelt TD. Maddocks-Christianson K, et al. Br J Haematol. 2007 Nov;139(3):398-404. doi: 10.1111/j.1365-2141.2007.06801.x. Br J Haematol. 2007. PMID: 17910629 Free article.

10

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features.

Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Bowen DA, et al. Among authors: schwager sm. Leuk Lymphoma. 2007 Dec;48(12):2412-7. doi: 10.1080/10428190701724801. Leuk Lymphoma. 2007. PMID: 18067017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters